How far back does this document actually reach?
A document is only as good as the chain that connects it to the material, and most chains here are two or three links longer than the paperwork admits.
Vendors
Page 2 of 48 of this archive, newest first.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
Changsha export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
A supplier suspends shipping to Australia after 11 consecutive customs detentions
The route did not close because of a rule about peptides.
What a 9% rise in coupling-reagent prices does to a 2 mg vial
Follow the resin, not the catalogue.
Nantong export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
Independent analysis puts a ERP cagrilintide lot at 98.8%, against 97.3% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
What changed at SGN in June, and what the company says prompted it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
PeptideMeter result on a Xianning semaglutide lot lands 4.4 points above the supplier’s stated figure
The supplier confirmed the determination and supplied the method behind its own figure inside a week.
Independent analysis puts a Homopeptide semaglutide lot at 96.0%, against 92.4% on the certificate
The result is unremarkable. What the report states alongside it is not.
Hong Kong export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
What a 37% rise in coupling-reagent prices does to a 20 mg vial
Follow the resin, not the catalogue.
Guangzhou export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
VendorInvestigate result on a Guangzhou retatrutide lot lands 4.2 points above the supplier’s stated figure
The result is unremarkable. What the report states alongside it is not.
What a 26% rise in coupling-reagent prices does to a 20 mg vial
Follow the resin, not the catalogue.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
Independent analysis puts a QYB mazdutide lot at 95.3%, against 92.9% on the certificate
The result is unremarkable. What the report states alongside it is not.
What changed at QST in May, and what the company says prompted it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
How a claim degrades between the bench and the listing
Lot-level verification with a public report is a real and achievable thing. It exists in this market, on a minority of listings.
PeptideMeter result on a Changsha mazdutide lot lands 4.4 points above the supplier’s stated figure
The report states the gradient, the wavelength and the integration threshold, which is more than most.